The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / July / The Hidden Signals of Oral Cancer Risk
Oncology Digital and computational pathology Bioinformatics Digital Pathology Research and Innovations Technology and innovation

The Hidden Signals of Oral Cancer Risk

AI-derived biomarkers could help pathologists identify high-risk lesions more consistently than traditional grading alone

By Jessica Allerton 07/20/2026 Discussion 4 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Top Institutions

Share

Clinical Report: The Hidden Signals of Oral Cancer Risk

Background

Oral epithelial dysplasia is a precancerous condition that is prevalent, particularly in lower- and middle-income countries, with a subset of cases progressing to oral cancer. Current diagnostic methods, primarily histological grading, are subjective and can lead to inconsistent treatment decisions. There is a pressing need for more reliable diagnostic tools to improve patient care and outcomes. [Citation needed]

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Histological grading of OED is subjective and varies significantly between pathologists.
  • Current grading does not reliably predict clinical outcomes, leading to potential over- or under-treatment.
  • HoVer-Net+ is an AI model that analyzes histology images at the nuclear level, providing biologically meaningful features for risk assessment.
  • AI-based models may offer more consistent risk predictions compared to traditional histological grading.
  • Quantitative risk assessment tools like the OMTscore and ODYN model have been developed to predict malignant progression from tissue images.

Clinical Implications

The integration of AI tools in the assessment of OED could support pathologists by providing additional information for clinical decision-making.

Conclusion

Continued research and validation of AI tools are essential for their clinical implementation.

Related Resources & Content

  1. conexiant, Conexiant, 2026 -- Mutational Signatures May Define Oral Cancers
  2. The ASCO Post, ASCO Post, 2026 -- Oral Cancer: Novel Diagnostic Test Demonstrates High Accuracy
  3. uci health, UCI Health, 2026 -- Advancing early detection during Head and Neck Cancer Awareness Month
  4. Oral Cancer Guideline | American Dental Association, American Dental Association, 2026 -- Oral Cancer Guideline
  5. Final Recommendation Statement: Oral Cancer: Screening | United States Preventive Services Taskforce, United States Preventive Services Taskforce, 2026 -- Oral Cancer Screening
  6. conexiant — Poor Diet Quality Linked to Oral Cancer
  7. https://www.oregon.gov/oha/HPA/DSI-HERC/MembersOnly/7.5f%20NCCN%201.2026%20head-and-neck.pdf
  8. Oral Cancer Guideline | American Dental Association
  9. Final Recommendation Statement: Oral Cancer: Screening | United States Preventive Services Taskforce
  10. Oral epithelial dysplasia: Do we have a management solution? A systematic review - ScienceDirect
  11. Frontiers | Malignant transformation rate of oral precancerous disorders to oral cancer: systematic review and meta-analysis of the current evidence
  12. Malignant transformation of proliferative Verrucous Leukoplakia—systematic review & meta-analysis | BMC Oral Health | Springer Nature Link
  13. DNA ploidy status as a predictor for malignant transformation in oral leukoplakia: a systematic review and meta-analysis - PubMed
  14. American Association of Oral and Maxillofacial Surgeon's Position Paper on Oral Mucosal Dysplasia - ScienceDirect
  15. I. Administrative information:
  16. Chapter 6: oral cancer - GOV.UK

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. AJ Shephard et al., Commun Med (Lond), 5, 186 (2025). PMID: 40394272.
  2. AJ Shephard et al., Br J Cancer, 132 (2025). PMID: 39616233.
  3. AJ Shephard et al., NPJ Precis Oncol, 8, 137 (2024). PMID: 38942998.
  4. H Mahmood et al., BR J Cancer, 129 (2023). PMID: 37758836.
  5. R Muhammad et al., J Pathol, 260, 4 (2023). PMID: 37294162.

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Digital and computational pathology
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Cracking Colon Cancer
Digital and computational pathology
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

The (Pathology) IT Crowd?
Digital and computational pathology
The (Pathology) IT Crowd?

December 30, 2021

5 min read

The pathologist’s guide to IT considerations for digitization

Defining the Next Generation of NGS
Digital and computational pathology
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.